Annual EBITDA
-$15.55 M
+$41.91 M+72.93%
December 31, 2023
Summary
- As of February 8, 2025, OPTN annual EBITDA is -$15.55 million, with the most recent change of +$41.91 million (+72.93%) on December 31, 2023.
- During the last 3 years, OPTN annual EBITDA has risen by +$69.77 million (+81.77%).
- OPTN annual EBITDA is now -159.33% below its all-time high of $26.21 million, reached on December 31, 2016.
Performance
OPTN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$5.83 M
+$8.39 M+327.22%
September 30, 2024
Summary
- As of February 8, 2025, OPTN quarterly EBITDA is $5.83 million, with the most recent change of +$8.39 million (+327.22%) on September 30, 2024.
- Over the past year, OPTN quarterly EBITDA has increased by +$8.39 million (+327.22%).
- OPTN quarterly EBITDA is now -22.91% below its all-time high of $7.56 million, reached on June 30, 2023.
Performance
OPTN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$10.51 M
+$10.08 M+48.96%
September 30, 2024
Summary
- As of February 8, 2025, OPTN TTM EBITDA is -$10.51 million, with the most recent change of +$10.08 million (+48.96%) on September 30, 2024.
- Over the past year, OPTN TTM EBITDA has increased by +$10.08 million (+48.96%).
- OPTN TTM EBITDA is now -101.90% below its all-time high of -$5.20 million, reached on September 30, 2016.
Performance
OPTN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
OPTN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +72.9% | +327.2% | +49.0% |
| 3 y3 years | +81.8% | +154.9% | +82.0% |
| 5 y5 years | +84.0% | +133.5% | +88.0% |
OPTN EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +76.3% | -22.9% | +127.6% | -0.4% | +84.0% |
| 5 y | 5-year | at high | +84.3% | -22.9% | +122.7% | -0.4% | +89.4% |
| alltime | all time | -159.3% | +84.3% | -22.9% | +120.6% | -101.9% | +89.6% |
OptiNose EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $5.83 M(-327.2%) | -$10.51 M(-49.0%) |
| Jun 2024 | - | -$2.56 M(-71.6%) | -$20.58 M(+96.7%) |
| Mar 2024 | - | -$9.01 M(+89.6%) | -$10.46 M(-32.7%) |
| Dec 2023 | -$15.55 M(-72.9%) | -$4.75 M(+11.9%) | -$15.55 M(-27.1%) |
| Sep 2023 | - | -$4.25 M(-156.3%) | -$21.34 M(-22.9%) |
| Jun 2023 | - | $7.56 M(-153.6%) | -$27.69 M(-45.1%) |
| Mar 2023 | - | -$14.10 M(+33.8%) | -$50.42 M(-12.2%) |
| Dec 2022 | -$57.46 M(-12.5%) | -$10.54 M(-0.6%) | -$57.46 M(-1.5%) |
| Sep 2022 | - | -$10.60 M(-30.1%) | -$58.36 M(-3.8%) |
| Jun 2022 | - | -$15.17 M(-28.2%) | -$60.65 M(-6.4%) |
| Mar 2022 | - | -$21.14 M(+84.8%) | -$64.81 M(-1.3%) |
| Dec 2021 | -$65.68 M(-23.0%) | -$11.44 M(-11.2%) | -$65.68 M(-11.5%) |
| Sep 2021 | - | -$12.89 M(-33.3%) | -$74.17 M(-5.7%) |
| Jun 2021 | - | -$19.33 M(-12.2%) | -$78.67 M(-3.6%) |
| Mar 2021 | - | -$22.01 M(+10.4%) | -$81.65 M(-4.3%) |
| Dec 2020 | -$85.32 M | -$19.94 M(+14.7%) | -$85.32 M(-2.7%) |
| Sep 2020 | - | -$17.39 M(-22.0%) | -$87.67 M(-9.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | -$22.30 M(-13.2%) | -$96.43 M(-2.4%) |
| Mar 2020 | - | -$25.68 M(+15.2%) | -$98.79 M(-0.5%) |
| Dec 2019 | -$99.32 M(+2.5%) | -$22.29 M(-14.8%) | -$99.32 M(-1.5%) |
| Sep 2019 | - | -$26.15 M(+6.0%) | -$100.83 M(+3.6%) |
| Jun 2019 | - | -$24.66 M(-5.9%) | -$97.28 M(+2.5%) |
| Mar 2019 | - | -$26.22 M(+10.2%) | -$94.88 M(-2.1%) |
| Dec 2018 | -$96.89 M(+102.6%) | -$23.79 M(+5.2%) | -$96.89 M(+4.7%) |
| Sep 2018 | - | -$22.61 M(+1.5%) | -$92.54 M(+11.5%) |
| Jun 2018 | - | -$22.26 M(-21.1%) | -$82.96 M(+20.3%) |
| Mar 2018 | - | -$28.22 M(+45.2%) | -$68.95 M(+43.9%) |
| Dec 2017 | -$47.83 M(-282.5%) | -$19.44 M(+49.2%) | -$47.91 M(+44.5%) |
| Sep 2017 | - | -$13.03 M(+57.8%) | -$33.15 M(+30.9%) |
| Jun 2017 | - | -$8.26 M(+15.0%) | -$25.32 M(+48.4%) |
| Mar 2017 | - | -$7.18 M(+53.6%) | -$17.06 M(+72.7%) |
| Dec 2016 | $26.21 M(-195.6%) | -$4.68 M(-10.1%) | -$9.88 M(+89.9%) |
| Sep 2016 | - | -$5.20 M | -$5.20 M |
| Dec 2015 | -$27.42 M | - | - |
FAQ
- What is OptiNose annual EBITDA?
- What is the all time high annual EBITDA for OptiNose?
- What is OptiNose annual EBITDA year-on-year change?
- What is OptiNose quarterly EBITDA?
- What is the all time high quarterly EBITDA for OptiNose?
- What is OptiNose quarterly EBITDA year-on-year change?
- What is OptiNose TTM EBITDA?
- What is the all time high TTM EBITDA for OptiNose?
- What is OptiNose TTM EBITDA year-on-year change?
What is OptiNose annual EBITDA?
The current annual EBITDA of OPTN is -$15.55 M
What is the all time high annual EBITDA for OptiNose?
OptiNose all-time high annual EBITDA is $26.21 M
What is OptiNose annual EBITDA year-on-year change?
Over the past year, OPTN annual EBITDA has changed by +$41.91 M (+72.93%)
What is OptiNose quarterly EBITDA?
The current quarterly EBITDA of OPTN is $5.83 M
What is the all time high quarterly EBITDA for OptiNose?
OptiNose all-time high quarterly EBITDA is $7.56 M
What is OptiNose quarterly EBITDA year-on-year change?
Over the past year, OPTN quarterly EBITDA has changed by +$8.39 M (+327.22%)
What is OptiNose TTM EBITDA?
The current TTM EBITDA of OPTN is -$10.51 M
What is the all time high TTM EBITDA for OptiNose?
OptiNose all-time high TTM EBITDA is -$5.20 M
What is OptiNose TTM EBITDA year-on-year change?
Over the past year, OPTN TTM EBITDA has changed by +$10.08 M (+48.96%)